Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Method for diagnosing esophageal cancer
US8945849B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8945849-B2 |
| Application number | US-99379209-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 21, 2009 |
| Priority date | May 21, 2008 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention relates to a composition, kit, or DNA chip for use in diagnosis of esophageal cancer, which comprises a plurality of polynucleotides selected from the group consisting of polynucleotides whose expression levels are varied in esophageal cancer tissues obtained from esophageal cancer patients when compared with cancer-free esophageal tissues obtained from esophageal cancer patients, mutants thereof, and fragments thereof, and to a method for detecting esophageal cancer using the composition, kit, or DNA chip.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for determining whether a human subject has an increased likelihood of having esophageal cancer, comprising: (1) obtaining a test sample of esophageal tissue, or peripheral lymph nodes or another organ suspected of metastasis from esophageal cancer cells, from the subject; (2) selecting a set of the EYA2, SERF1A and IGHG1 genes; (3) assaying the expression level of EYA2, SERF1A, and IGHG1 genes in the test sample obtained from the subject…
Assignees
Inventors
Classifications
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
- C12Q1/6886Primary
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8945849B2 cover?
- This invention relates to a composition, kit, or DNA chip for use in diagnosis of esophageal cancer, which comprises a plurality of polynucleotides selected from the group consisting of polynucleotides whose expression levels are varied in esophageal cancer tissues obtained from esophageal cancer patients when compared with cancer-free esophageal tissues obtained from esophageal cancer patients…
- Who is the assignee on this patent?
- Myomoto Akira, Kozono Satoko, Akiyama Hideo, and 5 more
- What technology area does this patent fall under?
- Primary CPC classification C12Q1/6886. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).